Toll-like receptor 9 deficiency induces osteoclastic bone loss via gut microbiota-associated systemic chronic inflammation

Abstract

Toll-like receptors (TLRs) play pivotal roles in inflammation and provide important links between the immune and skeletal systems. Although the activation of TLRs may affect osteoclast differentiation and bone metabolism, whether and how TLRs are required for normal bone remodeling remains to be fully explored. In the current study, we show for the first time that TLR9^−/− mice exhibit a low bone mass and low-grade systemic chronic inflammation, which is characterized by the expansion of CD4⁺ T cells and increased levels of inflammatory cytokines, including TNFα, RANKL, and IL1β. The increased levels of these cytokines significantly promote osteoclastogenesis and induce bone loss. Importantly, TLR9 deletion alters the gut microbiota, and this dysbiosis is the basis of the systemic inflammation and bone loss observed in TLR9^−/− mice. Furthermore, through single-cell RNA sequencing, we identified myeloid-biased hematopoiesis in the bone marrow of TLR9^−/− mice and determined that the increase in myelopoiesis, likely caused by the adaptation of hematopoietic stem cells to systemic inflammation, also contributes to inflammation-induced osteoclastogenesis and subsequent bone loss in TLR9^−/− mice. Thus, our study provides novel evidence that TLR9 signaling connects the gut microbiota, immune system, and bone and is critical in maintaining the homeostasis of inflammation, hematopoiesis, and bone metabolism under normal conditions.

References

[1] Tsukasaki M, Takayanagi H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol., 2019, 19: 626-642

[2] Terashima A et al. Sepsis-induced osteoblast ablation causes immunodeficiency. Immunity, 2016, 44: 1434-1443

[3] Madel MB et al. Immune function and diversity of osteoclasts in normal and pathological conditions. Front. Immunol., 2019, 10: 1408

[4] Li Y et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood, 2007, 109: 3839-3848

[5] Weitzmann MN, Ofotokun I. Physiological and pathophysiological bone turnover - role of the immune system. Nat. Rev. Endocrinol., 2016, 12: 518-532

[6] van Bodegraven AA, Bravenboer N. Perspective on skeletal health in inflammatory bowel disease. Osteoporos. Int., 2020, 31: 637-646

[7] Yu M et al. PTH induces bone loss via microbial-dependent expansion of intestinal TNF⁺ T cells and Th17 cells. Nat. Commun, 2020, 11

[8] Farr JN et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med., 2017, 23: 1072-1079

[9] D’Amelio P et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone, 2008, 43: 92-100

[10] Li JY et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J. Clin. Investig., 2016, 126: 2049-2063

[11] Iqbal J, Yuen T, Sun L, Zaidi M. From the gut to the strut: where inflammation reigns, bone abstains. J. Clin. Investig., 2016, 126: 2045-2048

[12] Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front. Immunol., 2014, 5: 461

[13] Hemmi H et al. A Toll-like receptor recognizes bacterial DNA. Nature, 2000, 408: 740-745

[14] Krug A et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity, 2004, 21: 107-119

[15] Guiducci C et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J. Exp. Med., 2010, 207: 2931-2942

[16] Kim PD et al. Toll-like receptor 9-mediated inflammation triggers alveolar bone loss in experimental murine periodontitis. Infect. Immun., 2015, 83: 2992-3002

[17] Bakker PJ et al. TLR9 mediates remote liver injury following severe renal ischemia reperfusion. PLoS One, 2015, 10: e0137511

[18] Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med., 2006, 203: 553-561

[19] Fischer A et al. The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis. J. Cell. Mol. Med., 2018, 22: 4399-4409

[20] Ito T et al. Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation. Am. J. Respir Crit. Care Med., 2009, 180: 1227-1238

[21] Summers SA et al. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J. Autoimmun., 2010, 35: 291-298

[22] Stanbery AG, Newman ZR, Barton GM. Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-gamma. Proc. Natl. Acad. Sci. USA, 2020, 117: 3074-3082

[23] Bossaller L et al. TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus. J. Immunol., 2016, 197: 1044-1053

[24] Christensen SR et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity, 2006, 25: 417-428

[25] Han SJ, Kim M, Novitsky E, D'Agati V, Lee HT. Intestinal TLR9 deficiency exacerbates hepatic IR injury via altered intestinal inflammation and short-chain fatty acid synthesis. FASEB J, 2020, 34: 12083-12099

[26] Hong CP et al. TLR9 regulates adipose tissue inflammation and obesity-related metabolic disorders. Obesity, 2015, 23: 2199-2206

[27] Liu Y, Seto NL, Carmona-Rivera C, Kaplan MJ. Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance. Lupus Sci. Med., 2018, 5: e000259

[28] Mande P et al. Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. J. Clin. Investig., 2018, 128: 2966-2978

[29] Bar-Shavit Z. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity, 2008, 41: 195-203

[30] Liu J et al. Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J. Biol. Chem., 2009, 284: 12512-12523

[31] Hou L, Sasaki H, Stashenko P. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection. Infect. Immun., 2000, 68: 4681-4687

[32] Takami M, Kim N, Rho J, Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J. Immunol., 2002, 169: 1516-1523

[33] Zou W, Schwartz H, Endres S, Hartmann G, Bar-Shavit Z. CpG oligonucleotides: novel regulators of osteoclast differentiation. FASEB J., 2002, 16: 274-282

[34] Amcheslavsky A, Bar-Shavit Z. Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase. J. Bone Miner. Res., 2007, 22: 1301-1310

[35] Amcheslavsky A, Hemmi H, Akira S, Bar-Shavit Z. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis. J. Bone Miner. Res., 2005, 20: 1692-1699

[36] Tai N, Wong FS, Wen L. TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. J. Immunol., 2013, 191: 2926-2937

[37] Liu M et al. Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes. Diabetologia, 2018, 61: 2333-2343

[38] Horowitz MC, Fretz JA, Lorenzo JA. How B cells influence bone biology in health and disease. Bone, 2010, 47: 472-479

[39] Netea MG et al. A guiding map for inflammation. Nat. Immunol., 2017, 18: 826-831

[40] Kawai VK, Stein CM, Perrien DS, Griffin MR. Effects of anti-tumor necrosis factor alpha agents on bone. Curr. Opin. Rheumatol., 2012, 24: 576-585

[41] Vijay-Kumar M et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science, 2010, 328: 228-231

[42] Wen L et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature, 2008, 455: 1109-1113

[43] Yu M et al. Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF⁺ T cells and Th17cells. J Clin. Investig, 2021, 131: e143137

[44] Caruso R et al. A specific gene-microbe interaction drives the development of Crohn’s disease-like colitis in mice. Sci. Immunol, 2019, 4: eaaw4341

[45] Lopetuso LR et al. Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders. Dig. Dis., 2018, 36: 56-65

[46] He C et al. MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1. Gastroenterology, 2017, 152: 1434-1448 e1415

[47] Caruso R, Ono M, Bunker ME, Nunez G, Inohara N. Dynamic and asymmetric changes of the microbial communities after cohousing in laboratory mice. Cell Rep., 2019, 27: 3401-3412 e3403

[48] Chavakis T, Mitroulis I, Hajishengallis G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat. Immunol., 2019, 20: 802-811

[49] Schultze JL, Mass E, Schlitzer A. Emerging principles in myelopoiesis at homeostasis and during infection and inflammation. Immunity, 2019, 50: 288-301

[50] Giladi A et al. Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis. Nat. Cell Biol., 2018, 20: 836-846

[51] Paul F et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell, 2015, 163: 1663-1677

[52] Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol., 1993, 13: 841-851

[53] Velten L et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nat. Cell Biol., 2017, 19: 271-281

[54] Mallampati S et al. Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1epsilon. Blood, 2014, 123: 4064-4076

[55] Oltz EM et al. A novel regulatory myosin light chain gene distinguishes pre-B cell subsets and is IL-7 inducible. EMBO J., 1992, 11: 2759-2767

[56] Maitra U, Gan L, Chang S, Li L. Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein delta. J. Immunol., 2011, 186: 4467-4473

[57] Balamurugan K et al. FBXW7alpha attenuates inflammatory signalling by downregulating C/EBPdelta and its target gene Tlr4. Nat. Commun., 2013, 4

[58] Caiado F, Pietras EM, Manz MG. Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp. Med, 2021, 218: e20201541

[59] Lee S et al. Bone marrow CX3CR1⁺ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice. Blood, 2019, 134: 1312-1322

[60] Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene, 2007, 26: 6816-6828

[61] Charles JF et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J. Clin. Investig., 2012, 122: 4592-4605

[62] Zhou X et al. Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity, 2010, 33: 229-240

[63] Ota Y et al. Generation mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis. Arthritis Res. Ther., 2016, 18: 67

[64] Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol., 2008, 8: 362-371

[65] Di Rosa F, Gebhardt T. Bone marrow T cells and the integrated functions of recirculating and tissue-resident memory T cells. Front. Immunol., 2016, 7: 51

[66] Souza PPC, Lerner UH. Finding a toll on the route: the fate of osteoclast progenitors after toll-like receptor activation. Front. Immunol., 2019, 10: 1663

[67] Sato N et al. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J. Exp. Med., 2004, 200: 601-611

[68] Guss JD et al. Alterations to the gut microbiome impair bone strength and tissue material properties. J. Bone Miner. Res., 2017, 32: 1343-1353

[69] Yokota K et al. Combination of tumor necrosis factor alpha and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. Arthritis Rheumatol., 2014, 66: 121-129

[70] Ruscitti P et al. The role of IL-1beta in the bone loss during rheumatic diseases. Mediators Inflamm., 2015, 2015: 782382

[71] Tilstra JS et al. B cell-intrinsic TLR9 expression is protective in murine lupus. J. Clin. Investig., 2020, 130: 3172-3187

[72] Al Sayed MF et al. T-cell-secreted TNFalpha induces emergency myelopoiesis and myeloid-derived suppressor cell differentiation in cancer. Cancer Res., 2019, 79: 346-359

[73] Ko CY, Chang WC, Wang JM. Biological roles of CCAAT/Enhancer-binding protein delta during inflammation. J. Biomed. Sci., 2015, 22: 6

[74] Kaufmann E et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell, 2018, 172: 176-190 e119

[75] Mitroulis I et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell, 2018, 172: 147-161 e112

[76] Yamamoto R et al. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell, 2013, 154: 1112-1126

[77] Chen L, Ozato K. Innate immune memory in hematopoietic stem/progenitor cells: myeloid-biased differentiation and the role of interferon. Front. Immunol., 2021, 12: 621333

[78] Jack GD, Zhang L, Friedman AD. M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification. Blood, 2009, 114: 2172-2180

[79] Satoh Y et al. The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity, 2013, 38: 1105-1115

[80] Etzrodt M et al. Inflammatory signals directly instruct PU.1 in HSCs via TNF. Blood, 2019, 133: 816-819

[81] Lodie TA, Savedra R Jr., Golenbock DT, Van Beveren CP, Maki RA. Fenton MJ. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol., 1997, 158: 1848-1856

[82] Zhang DE, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol., 1994, 14: 373-381

[83] Duan H, Li Z, Mazzone T. Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression. J. Clin. Investig., 1995, 96: 915-922

[84] Grigoriadis AE et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science, 1994, 266: 443-448

[85] Tong X et al. Overexpression of c-Fos reverses osteoprotegerin-mediated suppression of osteoclastogenesis by increasing the Beclin1-induced autophagy. J. Cell. Mol. Med, 2020, 25: 937-945

[86] Hernandez CJ, Guss JD, Luna M, Goldring SR. Links between the microbiome and bone. J. Bone Miner. Res., 2016, 31: 1638-1646

[87] Elinav E et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell, 2011, 145: 745-757

[88] Thevaranjan N et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe, 2017, 21: 455-466 e454

[89] Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol., 2009, 9: 313-323

[90] Lima CA, Lyra AC, Rocha R, Santana GO. Risk factors for osteoporosis in inflammatory bowel disease patients. World J. Gastrointest. Pathophysiol., 2015, 6: 210-218

[91] McFarlane L, Truong V, Palmer JS, Wilhelm D. Novel PCR assay for determining the genetic sex of mice. Sex. Dev., 2013, 7: 207-211

[92] Dempster DW et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res., 2013, 28: 2-17

[93] Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc., 2020, 15: 1484-1506

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81400855)

Natural Science Foundation of Shanghai (Natural Science Foundation of Shanghai Municipality)(21ZR1448600)

Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission)(14pj1407200)

National Key R&D Program of China grant no. 2018YFC1106300